Precision therapy could stop breast cancer at the source

Researchers at the University of California San Diego School of Medicine have identified a promising new therapy for triple-negative breast cancer (TNBC), which is among the most aggressive and difficult-to-treat forms of the disease.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup